Tardive Dyskinesia Therapeutics Market Growth Insights with Size Analysis
The global tardive dyskinesia (TD) therapeutics market has emerged as a crucial segment within the central nervous system (CNS) therapeutics landscape. In 2023, the market was valued at USD 3.83 billion and is projected to witness a compound annual growth rate (CAGR) of 4.3% throughout the forecast period. Tardive dyskinesia is a serious, often irreversible...
0 Comments 0 Shares 150 Views 0 Reviews